Article
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 May 2018
Mizuno Takashi, Cloyd Jordan M, Vicente Diego, Omichi Kiyohiko, Chun Yun Shin, Kopetz Scott E, Maru Dipen, Conrad Claudius, Tzeng Ching-Wei D, Wei Steven H, Aloia Thomas A, Vauthey Jean-Nicolas
Abstract excerpt
INTRODUCTION: Dorsophilia protein, mothers against decapentaplegic homolog 4 (SMAD4) is a key mediator in the transforming growth factor (TGF)-β signaling pathway and SMAD4 gene mutations are thought to play a critical role in colorectal cancer (CRC) progression. However, little is known about its influence on survival in patients undergoing resection for colorectal liver metastases (CLM). METHODS: Between 2005...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
